Substituent effects on solvolyses of 1,4-ethano-1,2,3,4-tetrahydronaphthalen-2(exo and endo)-yl [benzobicyclo[2.2.2]octen-2(exo and endo)-yl] derivatives
Substituent effects on solvolyses of 1,4-ethano-1,2,3,4-tetrahydronaphthalen-2(exo and endo)-yl [benzobicyclo[2.2.2]octen-2(exo and endo)-yl] derivatives
COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS
申请人:[en]NMD PHARMA A/S
公开号:WO2024121129A1
公开(公告)日:2024-06-13
The present disclosure relates to compounds suitable for treating, ameliorating and/or preventing neuromuscular disorders, including the reversal of drug-induced neuromuscular blockade. The compounds as defined herein can inhibit the CIC-1 ion channel.